Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Retrograde Analysis of Clinical Characteristics of Bone Metastasis in 1,031 Cases of Preliminarily Diagnosed Nasopharyngeal Carcinoma

  • Zhao, Chang-Lin (Department of Traditional Chinese Medicine, School of Medicine, Jinan University) ;
  • Qian, Guo-Qiang (Nursing Department of Huanghuai University) ;
  • Chen, Xiao-Yin (Department of Traditional Chinese Medicine, School of Medicine, Jinan University) ;
  • Chen, Chao (Department of Traditional Chinese Medicine, the First Affiliated Hospital of Jinan University)
  • Published : 2014.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To explore the clinical characteristics of bone metastasis (BM) in a large sample of preliminarily diagnosed nasopharyngeal carcinomas (NPCs). Methods: The sample consisted of 1,031 patients diagnosed with NPC at first visitg clinics between October 1989 and June 2012. Several parameters including metastasis locus, T/N staging, diagnosis, therapy and prognosis of BM were analyzed retrospectively. Results: In 70 patients who had been preliminarily diagnosed with BM, the incidence of BM in N0, N1, N2 and N3 stage was 5.7%, 17.2%, 50.2%, and 25.7%, respectively, while the incidence in T0, T1, T2 and T3 stage was 0%, 23.8%, 47.6% and 28.6% respectively. BM occurred in most common in vertebral column, rib, sternum, ilium and femur. Positive rate of Epstein-Barr virus antibody was 77.6%. The median survival time was 12 months. Conclusion: The incidence of BM in NPC preliminarily diagnosed is about 7% and it is related to N classification but not T classification.

Keywords

References

  1. Ahmad A, Stefani S (1986). Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol, 133, 194-7.
  2. Cao X, Han Y, He L, et al (2011). Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: Who will benefit from combined treatment? Oral Oncol, 47, 747-52. https://doi.org/10.1016/j.oraloncology.2011.05.010
  3. Chan AT, Lo YM, Zee B, et al (2002). Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. Natl Cancer Inst, 94, 1614-19. https://doi.org/10.1093/jnci/94.21.1614
  4. Chang JT, Chan SC, Yen TC, et al (2005). Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys, 62, 501-7. https://doi.org/10.1016/j.ijrobp.2004.09.057
  5. Cheng SH, James Jer-Min Jian, Stella Y. C. Tsai, et al (1998). Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys, 41, 755-62. https://doi.org/10.1016/S0360-3016(98)00092-3
  6. Fandi A, Bachouchi M, Azli N, et al (2000). Long-term diseasefree survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol, 18, 1324-30.
  7. Kwan WH, Teo PM, Chow LT, et al (1996). Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment. Clin Oncol (R Coll Radiol), 8, 55-8. https://doi.org/10.1016/S0936-6555(05)80041-X
  8. Lee AW, Poon YF, Foo W, et al (1992). Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1986: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 23, 261-70. https://doi.org/10.1016/0360-3016(92)90740-9
  9. Lo YM, Chan AT, Chan LY, et al (2000). Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res, 60, 6878-81.
  10. Mundy GR (2002). Metastasis to bone: cause, consequences, and therapeutic opportunity. Nat Rev Cancer, 2, 584-93. https://doi.org/10.1038/nrc867
  11. Nakamoto Y, Osman M, Wahl RL (2003). Prevalence and patterns of bone metastases detected with positron emission tomography using F 18 FDG. Clin Nucl Med, 28, 302-7.
  12. Ning-Bo Liu , Lei Zhu , Ming-Huan Li, et al (2013). Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis. Asian Pac J Cancer Prev, 14, 3647-52. https://doi.org/10.7314/APJCP.2013.14.6.3647
  13. Pan CC, Lu J, Yu JR, et al (2012). Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp Ther Med, 4, 334-8.
  14. Peng X, Chen S, Du C, et al (2013). Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment. Head Neck Oncol, 16, 21.
  15. Shanmugaratnam K , Sobin LH (1991). Histological typing of tumours of the upper respiratory tract and ear. In: K Shanmugaratnam and LH Sobin, Editors, International histological classification of tumours: WHO, Geneva 1991, 19, 32-3.
  16. Tang LL, Li WF, Chen L, et al (2010). Prognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imaging. Radiology, 257, 151-7. https://doi.org/10.1148/radiol.10100033
  17. Tang SGJ, Lin FJ, Chen MS, et al (1990). Prognostic factors of nasopharyngeal carcinoma: A multivariate analysis. Int J Radiat Oncol Biol Phys, 19, 1143-49. https://doi.org/10.1016/0360-3016(90)90219-A
  18. Teo PM, Kwan WH, Lee WY, et al (1996). Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer, 77, 2423-31. https://doi.org/10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N
  19. Tian-Ren Huang, Si-Wei Zhang, Wan-Qing Chen, et al (2012). Trends in Nasopharyngeal Carcinoma Mortality in China, 1973-2005. Asian Pac J Cancer Prev, 13, 2495-502. https://doi.org/10.7314/APJCP.2012.13.6.2495
  20. Yu-Shin Hung , Wen-Chi Chou , Tai-Di Chen, et al (2014). Prognostic Factors in Adult Patients with Solid Cancers and Bone Marrow Metastases. Asian Pac J Cancer Prev, 15, 61-7. https://doi.org/10.7314/APJCP.2014.15.1.61
  21. Wang TL, Tan YO (1991). Cisplatin and 5-fluorouracil continuous infusion for metastatic nasopharyngeal carcinoma. Ann Acad Med Singapore, 20, 601-3.
  22. Zhang EP, Lian PG, Cai KL, et al (1989). Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys, 16, 301-5. https://doi.org/10.1016/0360-3016(89)90318-0

Cited by

  1. Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature vol.14, pp.1, 2014, https://doi.org/10.1186/1471-2407-14-818
  2. Pathological Investigation of Vertebral Tumor Metastasis from Unknown Primaries - a Systematic Analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1047
  3. Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy vol.57, pp.4, 2016, https://doi.org/10.3349/ymj.2016.57.4.840